Cite
HARVARD Citation
Meijles, D. et al. (n.d.). 228 Braf inhibitors, sb590885 and dabrafenib, enhance erk1/2 signalling in cardiomyocytes and promote cardiac hypertrophy. Heart. pp. A146-A147. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Meijles, D. et al. (n.d.). 228 Braf inhibitors, sb590885 and dabrafenib, enhance erk1/2 signalling in cardiomyocytes and promote cardiac hypertrophy. Heart. pp. A146-A147. [Online].